You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Market Insight Series: Regulatory Affairs

Regulatory compliance is a core part of the life science industry, ensuring a competitive supply chain, promoting customer confidence and enabling profitable growth. The profession has also been developed from the desire of governmental organisations to protect public health by controlling the safety and efficacy of products.

Regulatory affairs monitors the safety of pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines

Recent changes to Regulatory Affairs

The last six months of the life sciences industry has very much been dominated by the Covid-19 pandemic. As a result of this, we are starting to see some impact on the sector. Life sciences companies that continued recruiting throughout the pandemic have found it easier with meeting business demands as opposed to those that paused who are now dealing with repercussions.

The last six months have also seen changes to the supply chain.

Now that the UK has become a third country due to Brexit, customs will be a mandatory requirement for goods passing between Ireland and the UK. While there are no specific requirements applying to medicines and medical devices there can still be delays to these items. These delays are due to items being shipped via mixed loads to the UK.

To view more industry news, case studies based on work completed by the Compass Life Sciences team, please click here.